Crypto Updates

BridgeBio Pharma’s Options: A Look at What the Big Money is Thinking

Veteran Trader Peter Brandt Asks Macro Guru If Bitcoin Bull Has Finally Awoken From Deep Slumber

Deep-pocketed investors have adopted a bullish approach towards BridgeBio Pharma (NASDAQ:BBIO), and it’s something market players shouldn’t ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BBIO usually suggests something big is about to happen.

We gleaned this information from our observations today when Benzinga’s options scanner highlighted 9 extraordinary options activities for BridgeBio Pharma. This level of activity is out of the ordinary.

The general mood among these heavyweight investors is divided, with 44% leaning bullish and 33% bearish. Among these notable options, 3 are puts, totaling $1,085,600, and 6 are calls, amounting to $400,980.

Projected Price Targets

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $30.0 to $55.0 for BridgeBio Pharma during the past quarter.

Insights into Volume & Open Interest

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for BridgeBio Pharma’s options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of BridgeBio Pharma’s whale trades within a strike price range from $30.0 to $55.0 in the last 30 days.

BridgeBio Pharma Option Activity Analysis: Last 30 Days

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
BBIO PUT TRADE BULLISH 08/16/24 $6.0 $4.1 $4.6 $30.00 $920.0K 654 0
BBIO PUT SWEEP BEARISH 08/16/24 $11.5 $11.4 $11.5 $40.00 $136.8K 247 145
BBIO CALL TRADE BULLISH 08/16/24 $0.45 $0.0 $0.45 $55.00 $112.5K 5.5K 0
BBIO CALL SWEEP BULLISH 08/16/24 $3.1 $3.0 $3.1 $35.00 $100.1K 3.0K 644
BBIO CALL SWEEP NEUTRAL 08/16/24 $1.65 $1.2 $1.6 $40.00 $80.0K 6.1K 500

About BridgeBio Pharma

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology,…

Click Here to Read the Full Original Article at Cryptocurrencies Feed…